Compliance· Oct 7, 2026
CLIA-Waived Test Cybersecurity: Point-of-Care Risks
CLIA-waived test cybersecurity: why point-of-care devices used by untrained staff need strong security, and what the FDA expects in the premarket submission.
Read articleEvery article in our archive in Compliance.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 12 of 15 articles in Compliance · Page 1 of 2
CLIA-waived test cybersecurity: why point-of-care devices used by untrained staff need strong security, and what the FDA expects in the premarket submission.
Read article
FDA cybersecurity deficiency response timeline: the 180-day clock, how holds work for 510(k), De Novo, and PMA, and a week-by-week plan to answer on time.
Read article
What is a cyber device under FDA Section 524B? The three-part legal test, how the FDA reads internet connection, and a quick check for your own device.
Read article
Where FDA premarket cybersecurity artifacts live in an ISO 13485 / QMSR quality system: DHF, risk management file, DMR, and postmarket - clause-by-clause map.
Read article
Cybersecurity for CLIA high-complexity labs: HIPAA, 21 CFR Part 11 data integrity, LIMS hardening, vendor patching, AI/cloud analytics, and CMS/CAP inspection readiness.
Read article
The FDA PCCP guidance isn't AI-only. Use a predetermined change control plan for cybersecurity patches, firmware updates, and SBOM component swaps.
Read article
FDA Section 524B applies to connected auto-injectors when the device constituent has software and any electronic interface, whether CDER or CDRH leads review.
Read article
What happens if you fail an FDA cybersecurity inspection: the 483-to-consent-decree enforcement ladder and the commercial fallout for device makers.
Read article
How to document update cadence for an FDA §524B submission: the regular cycle and the out-of-cycle expedited path reviewers expect under §524B(b)(2)(B).
Read article
FDA Section 524B applies to any new premarket submission for a cyber device, including legacy platforms.
Read article
A subsection-by-subsection walkthrough of FDA Section 524B for cyber medical devices: what §524B(a), (b)(1), (b)(2), (b)(3), (b)(4), and (c) require.
Read article
How to run CAPA for medical device cybersecurity findings: when a vulnerability or FDA deficiency triggers a CAPA, and what evidence closes it out.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ devices supported.